奥瑞克制药 ORIC
$8.82 +$0.33 (+3.89%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $8.82 0.00%
开盘$8.61
昨收$8.49
当日区间$8.50 – $8.93
成交量556.7K
市值$914.22M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例120.3%-2.39 个百分点，较上季度
持仓机构数211+1 ，较上季度
内部人近期交易23次买入 / 27次卖出净卖出
空头持仓比例14.88% 占流通股回补天数 10.5 · 截至 15 Oct 2026
卖空成交量占比29.0%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$5.07M（7个净流入日，13个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有31.3%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从21.06%降至14.88%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +1,535,826 | 1.5% |
| AIHC Capital Management Limited | Hedge Fund | 2026/Q3 | +1,368,909 | 3.7% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +1,229,771 | 6.4% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,191,804 | 4.7% |
| Algert Global LLC | Hedge Fund | 2026/Q3 | +1,078,943 | 1.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +839,421 | 6.6% |
| Jones Hill Capital LP | Hedge Fund | 2026/Q3 | +747,313 | 0.7% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +707,588 | 1.0% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +663,682 | 0.7% |
| Candriam, Société En Commandite Par Actions | Mutual Fund | 2026/Q3 | +605,683 | 1.1% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +603,664 | 0.6% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +593,368 | 1.7% |
| Integral Health Asset Management, LLC | Hedge Fund | 2026/Q3 | +500,000 | 1.8% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +382,716 | 0.6% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +344,542 | 1.7% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 19 Oct 2026 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -14,000 | $13.53 | 69,828 |
| 30 Sep 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Automatic Disposition | -3,200 | $12.91 | 241,772 |
| 30 Sep 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Derivative Exercise and Sale | -3,500 | $12.91 | 241,772 |
| 27 Sep 2026 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -13,400 | $13.53 | 69,828 |
| 23 Sep 2026 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -600 | $13.51 | 69,828 |
| 25 Aug 2026 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -77,000 | $13.69 | 69,828 |
| 23 Jul 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Open Market Disposition | -9,600 | $12.02 | 244,972 |
| 23 Jul 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Derivative Exercise and Sale | -3,500 | $12.02 | 244,972 |
| 5 Jul 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Automatic Disposition | -300 | $12.00 | 254,572 |
| 23 Feb 2026 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -52,000 | $13.51 | 68,148 |
| 15 Jan 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Automatic Disposition | -6,700 | $12.00 | 254,872 |
| 1 Jan 2026 | Pratik Multani | Chief Medical Officer | Other Derivative Acquisition | +35,500 | – | 35,500 |
| 1 Jan 2026 | Pratik Multani | Chief Medical Officer | Other Derivative Acquisition | +214,000 | $8.17 | 214,000 |
| 1 Jan 2026 | Angie You | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 | 40,000 |
| 1 Jan 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Other Derivative Acquisition | +40,000 | $8.17 | 40,000 |
| 1 Jan 2026 | Lori Kunkel | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 | 40,000 |
| 1 Jan 2026 | Mardi Dier | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 | 40,000 |
| 1 Jan 2026 | Jacob Chacko | Chief Executive Officer | Other Derivative Acquisition | +112,500 | – | 112,500 |
| 1 Jan 2026 | Jacob Chacko | Chief Executive Officer | Other Derivative Acquisition | +675,000 | $8.17 | 675,000 |
| 1 Jan 2026 | Steven Hoerter | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 | 40,000 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 15,422,384 | 14.9% | 10.5 |
| 30 Sep 2026 | 16,315,970 | 15.7% | 9.9 |
| 15 Sep 2026 | 17,532,473 | 16.9% | 14.2 |
| 31 Aug 2026 | 17,266,340 | 16.7% | 16.2 |
| 14 Aug 2026 | 18,392,742 | 17.7% | 11.0 |
| 31 Jul 2026 | 21,804,868 | 21.1% | 13.6 |
暂无评论——快来第一个聊聊 ORIC。
登录后参与讨论。